{"id":3468,"date":"2018-10-22T17:09:40","date_gmt":"2018-10-22T11:39:40","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=3468"},"modified":"2025-05-06T14:39:13","modified_gmt":"2025-05-06T09:09:13","slug":"insights-on-triple-negative-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer","title":{"rendered":"INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER"},"content":{"rendered":"
\"TRIPLE<\/a>

INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER<\/p><\/div>\n

 <\/p>\n

To know more about\u00a0TRIPLE NEGATIVE BREAST CANCER request for sample pages:\u00a0https:\/\/www.delveinsight.com\/dev-sample.php?form_name=Triple-Negative-Breast-Cancer-(TNBC)—Market-Insight,-Epidemiology-and-Market-Forecast-2027<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

  To know more about\u00a0TRIPLE NEGATIVE BREAST CANCER request for sample pages:\u00a0https:\/\/www.delveinsight.com\/dev-sample.php?form_name=Triple-Negative-Breast-Cancer-(TNBC)—Market-Insight,-Epidemiology-and-Market-Forecast-2027<\/p>\n","protected":false},"author":1,"featured_media":3471,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17434],"tags":[2013,2014,2012],"industry":[17225],"therapeutic_areas":[17228],"class_list":["post-3468","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-facts-and-figures","tag-insights-on-triple-negative-breast-cancer","tag-tnbc","tag-triple-negative-breast-cancer","industry-pharmaceutical","therapeutic_areas-oncology"],"acf":[],"yoast_head":"\nINSIGHTS ON TRIPLE NEGATIVE BREAST CANCER - DelveInsight Business Research<\/title>\n<meta name=\"description\" content=\"Breast cancer (BC) is the most common cancer in women worldwide; it affects ~12% of females in the United States.........\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER - DelveInsight Business Research\" \/>\n<meta property=\"og:description\" content=\"Breast cancer (BC) is the most common cancer in women worldwide; it affects ~12% of females in the United States.........\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-22T11:39:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-06T09:09:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/10\/15171458\/tnbc-fea.png\" \/>\n\t<meta property=\"og:image:width\" content=\"796\" \/>\n\t<meta property=\"og:image:height\" content=\"436\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER - DelveInsight Business Research","description":"Breast cancer (BC) is the most common cancer in women worldwide; it affects ~12% of females in the United States.........","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer","og_locale":"en_US","og_type":"article","og_title":"INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER - DelveInsight Business Research","og_description":"Breast cancer (BC) is the most common cancer in women worldwide; it affects ~12% of females in the United States.........","og_url":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2018-10-22T11:39:40+00:00","article_modified_time":"2025-05-06T09:09:13+00:00","og_image":[{"width":796,"height":436,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/10\/15171458\/tnbc-fea.png","type":"image\/png"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer","url":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer","name":"INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER - DelveInsight Business Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/10\/15171458\/tnbc-fea.png","datePublished":"2018-10-22T11:39:40+00:00","dateModified":"2025-05-06T09:09:13+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Breast cancer (BC) is the most common cancer in women worldwide; it affects ~12% of females in the United States.........","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/insights-on-triple-negative-breast-cancer#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/10\/15171458\/tnbc-fea.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/10\/15171458\/tnbc-fea.png","width":796,"height":436},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/10\/15171458\/tnbc-fea.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Facts and Figures<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Facts and Figures<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">TNBC<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">TRIPLE NEGATIVE BREAST CANCER<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER<\/span>","<span class=\"advgb-post-tax-term\">TNBC<\/span>","<span class=\"advgb-post-tax-term\">TRIPLE NEGATIVE BREAST CANCER<\/span>"]}},"comment_count":"2","relative_dates":{"created":"Posted 8 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Oct 22, 2018","modified":"Updated on May 6, 2025"},"absolute_dates_time":{"created":"Posted on Oct 22, 2018 5:09 pm","modified":"Updated on May 6, 2025 2:39 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=3468"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3468\/revisions"}],"predecessor-version":[{"id":31737,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3468\/revisions\/31737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/3471"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=3468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=3468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=3468"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=3468"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=3468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}